Hong Kong · SFC › Firms
Everest Medicines Limited
雲頂新耀有限公司
Hong Kong listed company Stock code 1952
Board members with SFC licence histories
Back to top ↑| Name | Position | From | To |
|---|---|---|---|
| Cho, William Ki Chul曹基哲 | Non-Executive Director | 12 Jan 2024 | present (as of 24 Dec 2025) |
| Woo, Ian Ying何穎 | President, Finance Director · Executive | Dec 2018 | present (as of 24 Dec 2025) |
| Gong, Yubo龔聿波 | Non-Executive Director | Jun 2020 | 9 Feb 2024 |
| Zhang, Xiaofan張曉帆 | Executive Director, Chief Operating Officer | Nov 2017 | 31 Mar 2023 |
| Tan, Bo譚擘 | Independent Non-Executive Director | 25 Sep 2020 | 19 Jan 2023 |
Listings
Back to top ↑| Market | Stock code | First traded | Delisted |
|---|---|---|---|
| SEHK Main Board | 1952 | 9 Oct 2020 | — |
Former names
Back to top ↑- Everest Medicines Limited · until 6 Oct 2020
Sources: Webb-site archive (Enigma database). Status checked with: SFC monthly report; SFC register snapshot; Webb-site archive (Enigma database). As of: 31 Oct 2026.
History comes from the Webb-site archive and is updated from public data. It may lag the official register, so check the SFC for the current position. Report an error.